Offer - Urjas Oil for just ₹ 1 X
Neufil is a commercial drug that is prescribed in the form of Injection. Neutropenia are some of its major therapeutic uses.
The right dosage of Neufil depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
While these are the most often observed Neufil side effects, there are can be others also. These have been listed below. Normally, these side effects of Neufil are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Neufil has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Neufil related warnings talks about Neufil's effects on the liver, heart and kidney.
Neufil is contraindicated in people with pre-existing medical conditions like Blood Cancer as it can result in adverse effects. Other conditions have been mentioned below in the Neufil contraindications section.
Drug interactions for Neufil have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Neufil is considered safe while driving, and is addictive.
Neufil is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Neufil safe for pregnant women?
Neufil may have some side effects during pregnancy. Pregnant women should discontinue the use of Neufil, and talk to their doctor, if they notice any discomfort.
Is the use of Neufil safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Neufil. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Neufil on the Kidneys?
Neufil rarely affects the kidneys.
What is the effect of Neufil on the Liver?
Neufil is rarely harmful for the liver.
What is the effect of Neufil on the Heart?
Neufil can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Neufil should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Neufil unless your doctor advises you to do so -
Is this Neufil habit forming or addictive?
Neufil is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Neufil since it does not cause drowsiness.
Is it safe?
Yes, Neufil is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Neufil is not used to treat mental disorders.
Interaction between Food and Neufil
Due to a lack of research, nothing can be said about the consequences of taking Neufil together with food.
Interaction between Alcohol and Neufil
Due to lack of research, there is no information about the side effects of taking Neufil with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560